AstraZeneca will add new millions of additional doses to the EU in the coming weeks

The President of the European Commission, Ursula von der Leyen, announced this morning that the pharmaceutical company AstraZeneca will receive several million additional doses of its vaccine against coronavirus en las proximas semanas.

“Paso adelante en vacunas. AstraZeneca will offer new millions of additional doses in the first quarter (40 million in total) in comparison with last week’s offer and will start the months one week before the preview”, Written by Von der Leyen on Twitter.

Von der Leyen, who held a virtual meeting with the AstraZeneca delegate and other pharmacists who agreed with the EU on the purchase of vacancies against the coronavirus, added that “The company will also expand its production capacity in Europe”.

Last week, the European Commission authorized the commercialization in all cases of the EU of the vaccine against the COVID-19 developed by AstraZeneca and the University of Oxford, which had previously received the good technical condition from the European Medicines Agency (EMA) for its administration to persons over 18 years of age.

This vacancy is to receive the conditional authorization inside the block, after the BioNTech y Pfizer and the Modern, which will be approved in December and its principles, respectively.

This vacuna, which demonstrates a 60% increase efficacy in analyzed clinical trials, it tends to be administered in dose doses, and the second injection should be discontinued between 4 and 12 weeks after the first dose.

The European Union reserves in August access to 300 million doses of AstraZeneca and Oxford vaccine (and the possibility of acquiring another 100 million more), for the legal authorization in full conflict between Brussels and society, which announced last week that only the future would include a quarter of the promised doses for the first trimester for production problems.

The explanations that the company has given since then have not reached the Executive Executive, which has demanded to respect the agreement, for example, sent vacancies from the plants that the laboratory has in United Kingdom.

Además, Bruselas suspects that AstraZeneca has sold three doses of products produced in the EU y este mismo viernes ha puesto en marcha an export vigilance system that could block the EU’s dose delivery lines if a pharmaceutical does not cooperate with its obligations to the summit.

(Relief from EFE and Europa Press)

MORE ABOUT THIS THEME:

The pandemic recruits in Brazil and regresses the ghost of impeachment for Bolsonaro

Global preoccupation with the Brazilian variant of coronavirus: all you need to know about the new cepa

Who is vaccinated against coronavirus